Glutamate concentrations vary with antiepileptic drug use and mental slowing

Tamar M. van Veenendaal, Dominique M. IJff, Albert P. Aldenkamp, Richard H C Lazeron, Nicolaas Puts, Richard Anthony Edward Edden, Paul A M Hofman, Anton J A de Louw, Walter H. Backes, Jacobus F A Jansen

Research output: Contribution to journalArticle

Abstract

Objective Although antiepileptic drugs (AEDs) are effective in suppressing epileptic seizures, they also induce (cognitive) side effects, with mental slowing as a general effect. This study aimed to assess whether concentrations of MR detectable neurotransmitters, glutamate and GABA, are associated with mental slowing in patients with epilepsy taking AEDs. Methods Cross-sectional data were collected from patients with localization-related epilepsy using a variety of AEDs from three risk categories, i.e., AEDs with low, intermediate, and high risks of developing cognitive problems. Patients underwent 3T MR spectroscopy, including a PRESS (n = 55) and MEGA-PRESS (n = 43) sequence, to estimate occipital glutamate and GABA concentrations, respectively. The association was calculated between neurotransmitter concentrations and central information processing speed, which was measured using the Computerized Visual Searching Task (CVST) and compared between the different risk categories. Results Combining all groups, patients with lower processing speeds had lower glutamate concentrations. Patients in the high-risk category had a lower glutamate concentration and lower processing speed compared with patients taking low-risk AEDs. Patients taking intermediate-risk AEDs also had a lower glutamate concentration compared with patients taking low-risk AEDs, but processing speed did not differ significantly between those groups. No associations were found between the GABA concentration and risk category or processing speed. Conclusions For the first time, a relation is shown between glutamate concentration and both mental slowing and AED use. It is suggested that the reduced excitatory action, reflected by lowered glutamate concentrations, may have contributed to the slowing of information processing in patients using AEDs with higher risks of cognitive side effects.

Original languageEnglish (US)
Pages (from-to)200-205
Number of pages6
JournalEpilepsy and Behavior
Volume64
DOIs
StatePublished - Nov 1 2016

Fingerprint

Anticonvulsants
Glutamic Acid
Risk-Taking
gamma-Aminobutyric Acid
Automatic Data Processing
Neurotransmitter Agents
Epilepsy
Partial Epilepsy
Magnetic Resonance Spectroscopy

Keywords

  • Anticonvulsant
  • Cognitive side effects
  • GABA
  • Glutamate
  • MR spectroscopy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

van Veenendaal, T. M., IJff, D. M., Aldenkamp, A. P., Lazeron, R. H. C., Puts, N., Edden, R. A. E., ... Jansen, J. F. A. (2016). Glutamate concentrations vary with antiepileptic drug use and mental slowing. Epilepsy and Behavior, 64, 200-205. https://doi.org/10.1016/j.yebeh.2016.08.027

Glutamate concentrations vary with antiepileptic drug use and mental slowing. / van Veenendaal, Tamar M.; IJff, Dominique M.; Aldenkamp, Albert P.; Lazeron, Richard H C; Puts, Nicolaas; Edden, Richard Anthony Edward; Hofman, Paul A M; de Louw, Anton J A; Backes, Walter H.; Jansen, Jacobus F A.

In: Epilepsy and Behavior, Vol. 64, 01.11.2016, p. 200-205.

Research output: Contribution to journalArticle

van Veenendaal, TM, IJff, DM, Aldenkamp, AP, Lazeron, RHC, Puts, N, Edden, RAE, Hofman, PAM, de Louw, AJA, Backes, WH & Jansen, JFA 2016, 'Glutamate concentrations vary with antiepileptic drug use and mental slowing', Epilepsy and Behavior, vol. 64, pp. 200-205. https://doi.org/10.1016/j.yebeh.2016.08.027
van Veenendaal, Tamar M. ; IJff, Dominique M. ; Aldenkamp, Albert P. ; Lazeron, Richard H C ; Puts, Nicolaas ; Edden, Richard Anthony Edward ; Hofman, Paul A M ; de Louw, Anton J A ; Backes, Walter H. ; Jansen, Jacobus F A. / Glutamate concentrations vary with antiepileptic drug use and mental slowing. In: Epilepsy and Behavior. 2016 ; Vol. 64. pp. 200-205.
@article{24c4f70c1eec430f9398af367ed15e4b,
title = "Glutamate concentrations vary with antiepileptic drug use and mental slowing",
abstract = "Objective Although antiepileptic drugs (AEDs) are effective in suppressing epileptic seizures, they also induce (cognitive) side effects, with mental slowing as a general effect. This study aimed to assess whether concentrations of MR detectable neurotransmitters, glutamate and GABA, are associated with mental slowing in patients with epilepsy taking AEDs. Methods Cross-sectional data were collected from patients with localization-related epilepsy using a variety of AEDs from three risk categories, i.e., AEDs with low, intermediate, and high risks of developing cognitive problems. Patients underwent 3T MR spectroscopy, including a PRESS (n = 55) and MEGA-PRESS (n = 43) sequence, to estimate occipital glutamate and GABA concentrations, respectively. The association was calculated between neurotransmitter concentrations and central information processing speed, which was measured using the Computerized Visual Searching Task (CVST) and compared between the different risk categories. Results Combining all groups, patients with lower processing speeds had lower glutamate concentrations. Patients in the high-risk category had a lower glutamate concentration and lower processing speed compared with patients taking low-risk AEDs. Patients taking intermediate-risk AEDs also had a lower glutamate concentration compared with patients taking low-risk AEDs, but processing speed did not differ significantly between those groups. No associations were found between the GABA concentration and risk category or processing speed. Conclusions For the first time, a relation is shown between glutamate concentration and both mental slowing and AED use. It is suggested that the reduced excitatory action, reflected by lowered glutamate concentrations, may have contributed to the slowing of information processing in patients using AEDs with higher risks of cognitive side effects.",
keywords = "Anticonvulsant, Cognitive side effects, GABA, Glutamate, MR spectroscopy",
author = "{van Veenendaal}, {Tamar M.} and IJff, {Dominique M.} and Aldenkamp, {Albert P.} and Lazeron, {Richard H C} and Nicolaas Puts and Edden, {Richard Anthony Edward} and Hofman, {Paul A M} and {de Louw}, {Anton J A} and Backes, {Walter H.} and Jansen, {Jacobus F A}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.yebeh.2016.08.027",
language = "English (US)",
volume = "64",
pages = "200--205",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Glutamate concentrations vary with antiepileptic drug use and mental slowing

AU - van Veenendaal, Tamar M.

AU - IJff, Dominique M.

AU - Aldenkamp, Albert P.

AU - Lazeron, Richard H C

AU - Puts, Nicolaas

AU - Edden, Richard Anthony Edward

AU - Hofman, Paul A M

AU - de Louw, Anton J A

AU - Backes, Walter H.

AU - Jansen, Jacobus F A

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Objective Although antiepileptic drugs (AEDs) are effective in suppressing epileptic seizures, they also induce (cognitive) side effects, with mental slowing as a general effect. This study aimed to assess whether concentrations of MR detectable neurotransmitters, glutamate and GABA, are associated with mental slowing in patients with epilepsy taking AEDs. Methods Cross-sectional data were collected from patients with localization-related epilepsy using a variety of AEDs from three risk categories, i.e., AEDs with low, intermediate, and high risks of developing cognitive problems. Patients underwent 3T MR spectroscopy, including a PRESS (n = 55) and MEGA-PRESS (n = 43) sequence, to estimate occipital glutamate and GABA concentrations, respectively. The association was calculated between neurotransmitter concentrations and central information processing speed, which was measured using the Computerized Visual Searching Task (CVST) and compared between the different risk categories. Results Combining all groups, patients with lower processing speeds had lower glutamate concentrations. Patients in the high-risk category had a lower glutamate concentration and lower processing speed compared with patients taking low-risk AEDs. Patients taking intermediate-risk AEDs also had a lower glutamate concentration compared with patients taking low-risk AEDs, but processing speed did not differ significantly between those groups. No associations were found between the GABA concentration and risk category or processing speed. Conclusions For the first time, a relation is shown between glutamate concentration and both mental slowing and AED use. It is suggested that the reduced excitatory action, reflected by lowered glutamate concentrations, may have contributed to the slowing of information processing in patients using AEDs with higher risks of cognitive side effects.

AB - Objective Although antiepileptic drugs (AEDs) are effective in suppressing epileptic seizures, they also induce (cognitive) side effects, with mental slowing as a general effect. This study aimed to assess whether concentrations of MR detectable neurotransmitters, glutamate and GABA, are associated with mental slowing in patients with epilepsy taking AEDs. Methods Cross-sectional data were collected from patients with localization-related epilepsy using a variety of AEDs from three risk categories, i.e., AEDs with low, intermediate, and high risks of developing cognitive problems. Patients underwent 3T MR spectroscopy, including a PRESS (n = 55) and MEGA-PRESS (n = 43) sequence, to estimate occipital glutamate and GABA concentrations, respectively. The association was calculated between neurotransmitter concentrations and central information processing speed, which was measured using the Computerized Visual Searching Task (CVST) and compared between the different risk categories. Results Combining all groups, patients with lower processing speeds had lower glutamate concentrations. Patients in the high-risk category had a lower glutamate concentration and lower processing speed compared with patients taking low-risk AEDs. Patients taking intermediate-risk AEDs also had a lower glutamate concentration compared with patients taking low-risk AEDs, but processing speed did not differ significantly between those groups. No associations were found between the GABA concentration and risk category or processing speed. Conclusions For the first time, a relation is shown between glutamate concentration and both mental slowing and AED use. It is suggested that the reduced excitatory action, reflected by lowered glutamate concentrations, may have contributed to the slowing of information processing in patients using AEDs with higher risks of cognitive side effects.

KW - Anticonvulsant

KW - Cognitive side effects

KW - GABA

KW - Glutamate

KW - MR spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=84991712182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991712182&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2016.08.027

DO - 10.1016/j.yebeh.2016.08.027

M3 - Article

VL - 64

SP - 200

EP - 205

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

ER -